Plain-English translation of NCT06705829 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research compares different ways of measuring how well your blood clots, particularly in people with liver disease or inherited bleeding disorders. The study uses blood samples that have already been collected during routine hospital care. Researchers want to understand which testing methods work best for detecting clotting problems in these patient populations.
Blood clotting tests are crucial for diagnosing bleeding disorders and liver disease, but different laboratory reagents (testing materials) may work differently. This trial exists to help hospitals and labs choose the most accurate testing methods for their patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, your involvement is minimal: researchers will use a blood sample that was already collected from you during a routine hospital visit. Your sample will be anonymized (your name will be removed) and tested with different laboratory methods to compare how well each one detects clotting problems. No additional visits or procedures are required from you.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France
Sponsor
University Hospital, Strasbourg, France
Enrollment target
~100 participants
Started
December 2024
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jordan Laurent WIMMER
University Hospital, Strasbourg, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.